Published in Microcirculation on April 29, 2009
Defects in oxygen supply to skeletal muscle of prediabetic ZDF rats. Am J Physiol Heart Circ Physiol (2010) 1.81
Anaerobic storage of red blood cells. Blood Transfus (2010) 1.34
Erythrocytes as controllers of perfusion distribution in the microvasculature of skeletal muscle. Acta Physiol (Oxf) (2010) 1.22
Homeostasis of extracellular ATP in human erythrocytes. J Biol Chem (2011) 1.04
Diamide decreases deformability of rabbit erythrocytes and attenuates low oxygen tension-induced ATP release. Exp Biol Med (Maywood) (2010) 0.99
Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase. Exp Biol Med (Maywood) (2010) 0.99
Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication. Microcirculation (2012) 0.98
Toward a multiscale description of microvascular flow regulation: o(2)-dependent release of ATP from human erythrocytes and the distribution of ATP in capillary networks. Front Physiol (2012) 0.97
Oxygen regulates the band 3-ankyrin bridge in the human erythrocyte membrane. Biochem J (2013) 0.87
A micro-delivery approach for studying microvascular responses to localized oxygen delivery. Microcirculation (2011) 0.86
What is the efficiency of ATP signaling from erythrocytes to regulate distribution of O(2) supply within the microvasculature? Microcirculation (2012) 0.86
Blood cells: an historical account of the roles of purinergic signalling. Purinergic Signal (2015) 0.78
Vascular disease in pre-diabetes: new insights derived from systems biology. Mo Med (2010) 0.75
Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes. Am J Physiol Regul Integr Comp Physiol (2013) 0.75
Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest (1994) 3.49
Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1992) 3.43
The erythrocyte as a regulator of vascular tone. Am J Physiol (1995) 3.40
Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines. Mechanism and structural determinants of activity. J Biol Chem (1990) 2.96
Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res (1992) 2.86
Deformation-induced ATP release from red blood cells requires CFTR activity. Am J Physiol (1998) 2.85
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol (1996) 2.64
Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem (2001) 2.42
ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol (1996) 2.23
Red blood cell regulation of microvascular tone through adenosine triphosphate. Am J Physiol Heart Circ Physiol (2000) 2.00
Role of erythrocyte in regulating local O2 delivery mediated by hemoglobin oxygenation. Am J Physiol Heart Circ Physiol (2001) 1.91
Red blood cell-derived ATP as a regulator of skeletal muscle perfusion. Med Sci Sports Exerc (2004) 1.89
Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab (2003) 1.88
Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care (2003) 1.84
The red blood cell as an oxygen sensor: what is the evidence? Acta Physiol Scand (2000) 1.64
Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release. Am J Physiol Cell Physiol (2001) 1.58
Microvascular function in human diabetes. A physiological perspective. Diabetes (1995) 1.51
A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase. Biochem J (1988) 1.42
Reduced expression of G(i) in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release. Diabetes (2006) 1.38
Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes. Am J Physiol Heart Circ Physiol (2003) 1.33
Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. Am J Physiol Heart Circ Physiol (2003) 1.33
Red not dead: signaling in and from erythrocytes. Trends Endocrinol Metab (2007) 1.29
Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP. Am J Physiol Heart Circ Physiol (2008) 1.22
Relationship of insulin resistance to microvascular dysfunction in subjects with fasting hyperglycaemia. Diabetologia (1997) 1.21
NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein Gi. Am J Physiol Heart Circ Physiol (2004) 1.16
Cell-permeable non-hydrolyzable cAMP derivatives as tools for analysis of signaling pathways controlling gene regulation in Dictyostelium. J Biol Chem (1993) 1.13
Reduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1994) 1.12
Microvascular vasodilatation in feet of newly diagnosed non-insulin dependent diabetic patients. BMJ (1991) 1.08
Rabbit erythrocytes possess adenylyl cyclase type II that is activated by the heterotrimeric G proteins Gs and Gi. Pharmacol Rep (2005) 1.07
Diabetes mellitus and macrovascular disease: mechanisms and mediators. Am J Med (2007) 1.05
Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium. Am J Physiol Heart Circ Physiol (2004) 1.03
Protein kinase C theta activation induces insulin-mediated constriction of muscle resistance arteries. Diabetes (2007) 1.00
Uptake of metabolites by postcapillary venules: mechanism for the control of arteriolar diameter. Microvasc Res (1993) 0.96
Oxygen sensitivity of vascular smooth muscle. II. In vivo studies. Am J Physiol (1974) 0.96
Reduced leg blood flow during submaximal exercise in type 2 diabetes. Med Sci Sports Exerc (2008) 0.95
Type 2 diabetes and cardiovascular disease: reducing the risk. J Manag Care Pharm (2007) 0.93
Reduced exercise arteriovenous O2 difference in Type 2 diabetes. J Appl Physiol (1985) (2002) 0.91
Relation of plasma insulin levels to forearm flow-mediated dilatation in healthy volunteers. Am J Cardiol (2006) 0.89
Hamster retractor muscle: a new preparation for intravital microscopy. Microvasc Res (1982) 0.88
Defects in microvascular haemodynamics during prediabetes: contributor or epiphenomenon? Diabetologia (2000) 0.87
Role of the cAMP-dependent protein kinase as the transducer of cAMP action. Biochem Pharmacol (1978) 0.86
Metabolic and vascular actions of endothelin-1 are inhibited by insulin-mediated vasodilation in perfused rat hindlimb muscle. Br J Pharmacol (2005) 0.81
Do we need to target 'prediabetic' hypertensive patients? J Hypertens (2005) 0.80
Erythrocytes: oxygen sensors and modulators of vascular tone. Physiology (Bethesda) (2009) 2.25
Colorectal cancer: how emerging molecular understanding affects treatment decisions. Oncology (Williston Park) (2014) 2.21
Synergistic effects of prostacyclin analogs and phosphodiesterase inhibitors on cyclic adenosine 3',5' monophosphate accumulation and adenosine 3'5' triphosphate release from human erythrocytes. Exp Biol Med (Maywood) (2013) 2.07
Pannexin 1 is the conduit for low oxygen tension-induced ATP release from human erythrocytes. Am J Physiol Heart Circ Physiol (2010) 1.81
Defects in oxygen supply to skeletal muscle of prediabetic ZDF rats. Am J Physiol Heart Circ Physiol (2010) 1.81
Reduced expression of G(i) in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release. Diabetes (2006) 1.38
Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes. Am J Physiol Heart Circ Physiol (2003) 1.33
Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. Am J Physiol Heart Circ Physiol (2003) 1.33
Red not dead: signaling in and from erythrocytes. Trends Endocrinol Metab (2007) 1.29
Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP. Am J Physiol Heart Circ Physiol (2008) 1.22
Regulation of blood flow distribution in skeletal muscle: role of erythrocyte-released ATP. J Physiol (2012) 1.18
NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein Gi. Am J Physiol Heart Circ Physiol (2004) 1.16
Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes. Microcirculation (2008) 1.09
Rabbit erythrocytes release ATP and dilate skeletal muscle arterioles in the presence of reduced oxygen tension. Pharmacol Rep (2009) 1.05
Nitric oxide inhibits ATP release from erythrocytes. J Pharmacol Exp Ther (2004) 1.03
Diamide decreases deformability of rabbit erythrocytes and attenuates low oxygen tension-induced ATP release. Exp Biol Med (Maywood) (2010) 0.99
Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase. Exp Biol Med (Maywood) (2010) 0.99
Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication. Microcirculation (2012) 0.98
Prostacyclin receptor-mediated ATP release from erythrocytes requires the voltage-dependent anion channel. Am J Physiol Heart Circ Physiol (2011) 0.98
A selective phosphodiesterase 3 inhibitor rescues low PO2-induced ATP release from erythrocytes of humans with type 2 diabetes: implication for vascular control. Am J Physiol Heart Circ Physiol (2011) 0.98
Toward a multiscale description of microvascular flow regulation: o(2)-dependent release of ATP from human erythrocytes and the distribution of ATP in capillary networks. Front Physiol (2012) 0.97
Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans. Am J Physiol Heart Circ Physiol (2009) 0.92
Identification of cytosolic phosphodiesterases in the erythrocyte: a possible role for PDE5. Med Sci Monit (2011) 0.91
Divergent effects of low-O(2) tension and iloprost on ATP release from erythrocytes of humans with type 2 diabetes: implications for O(2) supply to skeletal muscle. Am J Physiol Heart Circ Physiol (2010) 0.90
Electrospray ionization tandem mass spectrometry of sodiated adducts of cholesteryl esters. Lipids (2011) 0.89
Regulation of cAMP by phosphodiesterases in erythrocytes. Pharmacol Rep (2010) 0.87
Erythrocytes of humans with cystic fibrosis fail to stimulate nitric oxide synthesis in isolated rabbit lungs. Am J Physiol Heart Circ Physiol (2004) 0.85
Protein kinases A and C regulate receptor-mediated increases in cAMP in rabbit erythrocytes. Am J Physiol Heart Circ Physiol (2009) 0.85
5,6-EET-induced contraction of intralobar pulmonary arteries depends on the activation of Rho-kinase. J Appl Physiol (1985) (2005) 0.84
Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit. Am J Physiol Heart Circ Physiol (2003) 0.83
Lactate interferes with ATP release from red blood cells. Am J Physiol Heart Circ Physiol (2007) 0.83
Inhibition of ATP release from erythrocytes: a role for EPACs and PKC. Microcirculation (2011) 0.82
Cyclooxygenase (COX)-1 and COX-2 participate in 5,6-epoxyeicosatrienoic acid-induced contraction of rabbit intralobar pulmonary arteries. J Pharmacol Exp Ther (2007) 0.80
Reply by the authors to the comments of Mortimer Lorber, MD. Exp Biol Med (Maywood) (2014) 0.75
Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes. Am J Physiol Regul Integr Comp Physiol (2013) 0.75